Why Lululemon (LULU) Stock Is Falling Today
Earlier in the day, President Trump confirmed that Japan and South Korea would face new 25% tariffs on their imports to the US, effective August 1st. These announcements came ahead of the broader July 9th expiration of a 90-day pause on reciprocal tariffs, which failed to produce comprehensive trade deals with most nations. This action against two major trading partners, coupled with the ongoing threat of further tariffs on countries associated with the BRICS bloc, injected significant uncertainty and apprehension into global markets. Investors were likely reacting to the increased costs for businesses, potential disruptions to global supply chains, and the broader implications for international trade relations.
The stock market overreacts to news, and big price drops can present good opportunities to buy high-quality stocks. Is now the time to buy Lululemon? Access our full analysis report here, it's free.
Lululemon's shares are somewhat volatile and have had 14 moves greater than 5% over the last year. In that context, today's move indicates the market considers this news meaningful but not something that would fundamentally change its perception of the business.
Lululemon is down 36.6% since the beginning of the year, and at $235.97 per share, it is trading 44% below its 52-week high of $421.16 from January 2025. Investors who bought $1,000 worth of Lululemon's shares 5 years ago would now be looking at an investment worth $769.27.
Unless you've been living under a rock, it should be obvious by now that generative AI is going to have a huge impact on how large corporations do business. While Nvidia and AMD are trading close to all-time highs, we prefer a lesser-known (but still profitable) semiconductor stock benefiting from the rise of AI. Click here to access our free report on our favorite semiconductor growth story.
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Yahoo
8 minutes ago
- Yahoo
Defi Tokens Are Soaring, Leaving Behind OG Coins Like LTC, BCH and XMR
Bitcoin's surge to an all time high on Thursday evoked mixed reactions from altcoins, with some outperforming the largest cryptocurrency by market cap and others lagging behind. And that's split along industry lines. Tokens associated with decentralized finance (DeFi) and those from layer-2 blockchains are outperforming as investors transition to a risk-on approach. Others, such as tron (TRX), bitcoin cash (BCH), litecoin (LTC) and monero (XMR) are, in comparison, barely moving. Even solana (SOL), the darling of the previous drive to record highs, seems to be taking a back seat, rising just 3.9% while the likes of sei (SEI), ethena (ENA) and optimism (OP) are celebrating gains of as much as 28%. "Altcoins are leading the pack in this latest rally," Thomas Perfumo, Kraken's global economist, said in an email. A drop in bitcoin dominance is "reinforcing a broad-based rally with altcoins leading the charge." During the 2017 and 2021 runs to record highs, bitcoin dominance — a measure of BTC's share of the total crypto market —rose rapidly. On Thursday's rally, it fell to 63.5% from 64%, indicating a shift in emphasis toward the altcoin market Crypto markets are cyclical by nature. They run without interruption 24 hours a day against a backdrop of high volatility and low liquidity which can create an emotional trading environment. In previous cycles, altcoins often moved in unison, rising as bitcoin consolidated and dropping en masse when it rose or fell. This time, however, seems different, possibly due to the increased participation of institutions in the the industry. The rise in DeFi tokens can be attributed to increasing institutional interest in ether (ETH), which could pave the way for a search for yield with firms battling to secure the highest returns. The same can be said for layer-2 networks. As institutions run into the Ethereum blockchain's issues with latency and efficiency, they may consider networks like Arbitrum that allow liquidity to flow from decentralized exchanges to staking protocols at a fast rate. That network's ARB token is up 15% in the past 24 hours. Still, Petr Kozyakov, CEO at payments firm Mercuryo, said the rise in altcoins will be short-lived. "While altcoins are also in the green with Ethereum spiking past the $3,000 mark, the underlying 'orange pill' narrative remains steadfastly in place," he said. "Bitcoin's growing status as a store of value is one that more and more big players and institutions are simply unable to ignore." That's not a narrative that finds much support from Arthur Hayes, the BitMEX founder turned fund manager. 'Get ready for a monster alt season,' he told his followers on X after predicting that ETH would reach $10,000 this cycle. If Hayes' prediction holds true, bitcoin could face short-term difficulty as liquidity will inevitably flow into the altcoin market as traders attempt to capture speculative gains. This could also be a hammer blow to the old-school crypto coins, which all lack major catalysts for a boost. Sign in to access your portfolio
Bloomberg
9 minutes ago
- Bloomberg
European Stocks Rise on Possible US Trade Talks; Tech Gains
European stocks ticked up on Tuesday after US President Donald Trump indicated he is open to more trade negotiations with the European Union and Nvidia Corp. said it planned to resume sales of its H20 AI chip to China after securing Washington's backing. The Stoxx Europe 600 Index rose 0.1% as of 9:24 a.m. in Paris. Tech stocks and firms involved in the chip supply chain outperformed, boosted by Trump administration's dramatic reversal on H20 AI chip sales. ASML, BE Semiconductor, STMicro and Infineon were top gainers.
Medscape
17 minutes ago
- Medscape
Revolutionizing Anesthesia Drug Management and Integrity
Stocking and restocking anesthesia carts is tedious and meticulous — and it's highly regulated. Anesthesiologists have direct and extensive access to controlled drugs in a hospital setting, particularly potent opioids and sedatives, which makes these processes vulnerable to the potential of abuse. Within the anesthesia ecosystem, the doctor has a partner in the stocking and restocking process, and that's the hospital pharmacy staff. This team has so much reporting to do: logging which medications were used by which operating teams and on which patients — data that ultimately get reported to the Drug Enforcement Administration. Errors in any part of the dispensing, stocking, and securing process could result in waste, fines, medication errors, or worse. Hospitals have been on the search for help. Several companies have focused on what's called RAIN RFID. The technology uses passive ultrahigh frequency waves to essentially perform the function of Bluetooth or Wi-Fi for short-range device communication. It's available to hospitals to help with everything from patient tracking to equipment security and compliance. For anesthesia departments, the company Intelliguard created what it calls the Mira Ecosystem. It's built on RAIN RFID and monitors each vial of medication through its entire journey, filling clinical, compliance, and supply chain functions. Tray Setups and Refills Are Quick, Easy, and Traceable According to Intelliguard, about 90% of its systems are currently deployed to serve anesthesia departments. When vials of medication arrive at the pharmacy, a technician applies the Mira tag to each vial, and immediately, the system begins tracking each individual one. 'Our system reads each of the 96-bit unique IDs and then associates those unique IDs with the medication. So now each of those IDs is associated with rocuronium, for example, and the company that made it, the serial number, and the expiration and the lot number,' said Paul Elizondo, Intelliguard's chief innovation officer. 'From then on, when our system sees that 96-bit unique ID, it associates it with the medication in a database. It displays that on the screen, and we know exactly what that medication is now.' Paul Elizondo The system tracks each vial of medication throughout its journey at the hospital, giving pharmacy managers and hospital administrators instant, real-time visibility into where each vial is and when. In terms of daily pharmacy tasks, making up medication trays for anesthesiologists is made nearly foolproof, reducing medication errors. 'The hospitals using our system will place these RFID-tagged medications into the tray, then they will place that tray into our enclosure,' said Elizondo. 'In 6 seconds, we read every single tag in that tray, and we let them know if that formula, if what's in the tray, matches the formulary to which they're building right at that time.' The system can also check to ensure there are no expired or recalled medications in the tray. The real-time savings come, though, when the anesthesiologist returns the tray at the end of the day. Rady Children's Hospital in San Diego is using this system. Performance improvement pharmacist Ann McKinstry explained some of the ways that she's seen return on investment gains. 'Pinpointing the medication location has allowed for a more rapid response to expiry, recalls, and patient care events,' McKinstry said. 'Inpatient pharmacy inventory is tightened by offering a streamlined data review to analyze usage and reducing waste by tightening supply on hand. In addition, RFID tags allow accurate controlled substance reconciliation by monitoring usage, waste, and replenishment down to the minute.' Real-Time Tracking of Medication Location Saves a Life Knowing exactly where your medications are on a real-time basis isn't just important: It can be a matter of life and limb. For example, if a patient with a deadly North American pit viper bite is rolled into your emergency department, as happened at a Bartow, Florida hospital at 1 AM on May 4 — you'd definitely want to know if you have antivenom on hand. Bartow was out. They reached out to Prodigy Health, distributor of specialty pharmaceuticals that supplies medicines to hospitals on a consignment basis. Prodigy runs a 24-hour switchboard and uses RAIN to gain visibility into what is being dispensed by each hospital. The antivenom was quickly located at a hospital in Lutz, Florida, one that had a RAIN RFID cabinet. The request was made, the antivenom was transferred, and the day was saved. Ty Dishman Before this technology, 'This process was manual and time-consuming. Now, with reliable data integrating into our system every 6 seconds, we're able to provide immediate, confident answers to customer inquiries about medication availability and delivery timelines,' said Ty Dishman, CEO of Prodigy Health. 'Instead of saying, 'I think it's there — let me check and call you back,' we can act quickly and efficiently, ensuring life-saving medications are mobilized without delay.' The Competitive Landscape RFID systems are nothing new in the healthcare environment. They're commonly used to track medical equipment and inventory, as well as in staff badging systems. Its use in medication management is fairly recent. Terso Solutions offers a similar suite to the Mira Ecosystem, with the exception of Intelliguard's direct-to-operating room tray system; Avery Dennison Medical and Healthcare provides a wide range of pharmaceutical labeling options, and some options include RFID.
